ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AAHX Arana Therap.

50.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Arana Therap. LSE:AAHX London Ordinary Share AU000000AAH8 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 50.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Director's Share Purchase

06/12/2007 9:30am

UK Regulatory


RNS Number:3151J
Arana Therapeutics Limited
06 December 2007


For Immediate Release                                            6 December 2007


                             ARANA THERAPEUTICS LTD


                           DIRECTOR'S SHARE PURCHASE


Arana Therapeutics Ltd, (LSE: AAHx ASX: AAH) ("Arana" or the "Company"), the
Australian biopharmaceutical company, formed through the merger of Peptech and
EvoGenix in August 2007. The Company uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer. The Company has received notification on 3 December 2007
that the following Director purchased ordinary fully paid shares in the capital
of the Company. Details are as follows:


Director        Direct or   No. of     Date             Price per    Total           Subsequent
                Indirect    Ordinary   Purchased        Share (A$)   Consideration   beneficial
                Interest    Shares                                   (A$)            holding
                            purchased   

                                   
Robin Beaumont  Indirect    13,352     3 December 2007  1.147        15,312           139,000
                       
                                





For further information, please contact:

Arana Therapeutics Ltd
Dr John Chiplin, Chief Executive Officer              +61 (0)2 9870 8788
Niall Henderson, Chief Financial Officer              +61 (0)2 9870 8788

Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com)                 +44 (0)20 7466 5000
Rebecca Skye Dietrich / Catherine Breen

Nomura Code Securities
Charles Walker                                        +44 (0)20 7776 1206






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSFSWSUMSWSEEE

1 Year Arana Therap. Chart

1 Year Arana Therap. Chart

1 Month Arana Therap. Chart

1 Month Arana Therap. Chart